Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth R Carson

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Leukemia & Lymphoma|May 14, 2013
The characteristics and outcomes of patients with multiple myeloma dual refractory or intolerant to bortezomib and lenalidomide in the era of carfilzomib and pomalidomideTzu-Fei Wang, Rohan Ahluwalia, Mark A Fiala, et al.
Cancer Journal (Sudbury, Mass.)|September 26, 2025
Mitigating the Impact of Drug Shortages in Oncology: Lessons Learned From the 2023 Shortages of Carboplatin and CisplatinMaxwell L Izen, June M McKoy, Linda Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among VeteransMichael S Wolf, Karen A Fitzner, Eowyn F Powell, et al.
Cancer Journal (Sudbury, Mass.)|September 26, 2025
Cancer Drugs and United States Tariffs: Attention Must Be PaidMaxwell L Izen, June M McKoy, Linda Martin, et al.
Blood|December 5, 2014
Five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
Hematology. American Society of Hematology. Education Program|February 20, 2015
Five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
Plos One|September 25, 2024
A SONAR report on Nirmatrelvir/ritonavir-associated rebound COVID-19: Using new databases for evaluating new diseasesCharles L Bennett, Joseph Magagnoli, Krishna Gundabolu, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 14, 2020
Outcomes of Patients with Transformed Mycosis Fungoides: Analysis from a Prospective Multicenter US Cohort StudyFrederick Lansigan, Steven M Horwitz, Lauren C Pinter-Brown, et al.
JAMA Oncology|May 26, 2018
Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical TrialsJeremy M O'Connor, Kristen L Fessele, Jean Steiner, et al.
Journal of Geriatric Oncology|January 24, 2015
Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphomaKenneth R Carson, Peter Riedell, Ryan Lynch, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Leukemia & Lymphoma|May 14, 2013
The characteristics and outcomes of patients with multiple myeloma dual refractory or intolerant to bortezomib and lenalidomide in the era of carfilzomib and pomalidomideTzu-Fei Wang, Rohan Ahluwalia, Mark A Fiala, et al.
Cancer Journal (Sudbury, Mass.)|September 26, 2025
Mitigating the Impact of Drug Shortages in Oncology: Lessons Learned From the 2023 Shortages of Carboplatin and CisplatinMaxwell L Izen, June M McKoy, Linda Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among VeteransMichael S Wolf, Karen A Fitzner, Eowyn F Powell, et al.
Cancer Journal (Sudbury, Mass.)|September 26, 2025
Cancer Drugs and United States Tariffs: Attention Must Be PaidMaxwell L Izen, June M McKoy, Linda Martin, et al.
Blood|December 5, 2014
Five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
Hematology. American Society of Hematology. Education Program|February 20, 2015
Five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
Plos One|September 25, 2024
A SONAR report on Nirmatrelvir/ritonavir-associated rebound COVID-19: Using new databases for evaluating new diseasesCharles L Bennett, Joseph Magagnoli, Krishna Gundabolu, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 14, 2020
Outcomes of Patients with Transformed Mycosis Fungoides: Analysis from a Prospective Multicenter US Cohort StudyFrederick Lansigan, Steven M Horwitz, Lauren C Pinter-Brown, et al.
JAMA Oncology|May 26, 2018
Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical TrialsJeremy M O'Connor, Kristen L Fessele, Jean Steiner, et al.
Journal of Geriatric Oncology|January 24, 2015
Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphomaKenneth R Carson, Peter Riedell, Ryan Lynch, et al.
Pageof 10